Advancing Objective Assessment Through Optical Colorimetry
Acute otitis media (AOM) remains one of the most prevalent infectious conditions in pediatric practice and a leading cause of medical consultation and antibiotic prescription worldwide. Although contemporary clinical guidelines are well established, diagnostic
variability continues to influence management decisions, particularly in early-stage presentations where inflammatory changes may be
subtle.
Accurate assessment at this stage is clinically consequential. It shapes monitoring strategies, follow-up intervals, and prescribing
decisions. Enhancing diagnostic objectivity, therefore, is not a matter of convenience; it is central to responsible pediatric care.
Metablue Solution developed Otitest™ in response to this challenge: to introduce structured optical measurement into the assessment of
tympanic membrane inflammation.
The Physiological Basis for Optical Assessment
Inflammation of the middle ear induces measurable physiological changes. Increased vascular perfusion alters the chromatic properties of the tympanic membrane, affecting red color intensity, saturation, translucency, and light reflectance.
Traditional otoscopic examination relies on visual interpretation of these changes. However, visual assessment is influenced by multiple
variables, including illumination, device optics, examiner experience, patient cooperation, and anatomical variation. Even within
specialist settings, borderline or early inflammatory findings may generate interpretive variability. Optical colorimetric analysis builds upon the physiological premise that inflammatory hyperemia produces quantifiable changes in reflected light. By capturing and transforming these signals into structured numerical parameters, it becomes possible to reduce reliance on purely subjective interpretation.
From Visual Impression to Quantified Parameters
Otitest is a non-invasive medical device designed to measure reflected color data from the ear canal and tympanic membrane using controlled optical technology.
The system captures RGB (Red, Green, Blue) values and converts them into HSV (Hue, Saturation, Value) space, enabling refined
characterization of chromatic intensity and tonal variation. This mathematical transformation allows differentiation between baseline
anatomical coloration and inflammation-associated hyperemia through measurable variation. Results are presented on a structured probability scale ranging from 0 to 4. This grading framework supports consistent monitoring and clearer decision pathways regarding observation or medical consultation.
Otitest is not intended to replace physician diagnosis. It is designed to provide reproducible optical data that may complement clinical
evaluation and support structured follow-up.
Integrated Contextual Assessment
Recognizing that fever frequently accompanies middle ear infection, Otitest integrates infrared temperature measurement within the
same device architecture. The combination of tympanic coloration analysis and temperature assessment allows for contextual
interpretation within a unified framework. This integration reflects a broader design philosophy: meaningful measurement should be both physiologically grounded and clinically relevant.
Regulatory Governance and Development Standards
Otitest has been developed within the European regulatory framework for medical devices under Regulation (EU) 2017/745. Product development and manufacturing processes are aligned with EN ISO 13485 quality management standards and EN ISO 14971 risk
management principles. Electrical safety and performance comply with applicable IEC 60601 series standards for medical electrical equipment. Calibration protocols, defined disinfection procedures, contraindication guidance, and usability considerations are embedded within the device lifecycle.
At Metablue Solution, regulatory alignment is foundational. Innovation is pursued within established governance structures to ensure safety, reliability, and clinical responsibility.
Implications for Clinical Practice
Acute otitis media continues to represent a significant driver of pediatric antibiotic prescribing. Contemporary guidelines emphasize
careful assessment and, in selected cases, structured observation.
Technologies that enhance diagnostic clarity may indirectly support antimicrobial stewardship by improving confidence in monitoring
strategies and facilitating more informed clinical discussions. Structured optical measurement introduces reproducibility into a domain historically dependent on descriptive evaluation.
In recurrent otitis or follow-up scenarios, the ability to generate consistent probability grading may further support longitudinal
assessment.
A Measured Advancement in Pediatric Ear Health
AOM evaluation has long depended on visual interpretation as its primary diagnostic modality. While fundamental to clinical practice,
this approach remains susceptible to variability. By translating physiological color changes into quantifiable parameters, Otitest introduces a reproducible dimension to early ear assessment. The objective is not disruption, but refinement , strengthening clinical confidence through measurable support.
Metablue Solution’s development philosophy reflects a broader commitment: medical technology grounded in physiology, validated
within regulatory frameworks, and designed to complement professional expertise. In a condition as prevalent as acute otitis media, incremental improvements in diagnostic clarity carry meaningful impact.